Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Bravelle 75I.U Injection

Prescription Icon
Prescription Required

Marketer

Ferring Pharmaceuticals

Salt Composition

Urofollitropin (75i.u)

Overview Bravelle 75I.U Injection

For women experiencing infertility, Bravelle 75 IU Injection aids in stimulating ovulation, proving beneficial during fertility treatments such as IVF. Administered via injection under medical supervision, self-injection techniques are taught by healthcare professionals. Dosage and frequency are determined individually by your physician, who will also schedule injections appropriately. Concurrently, other medications may be prescribed. Treatment duration aligns with your doctor's instructions. Common side effects include abdominal pain or cramping, headaches, bloating, pelvic discomfort, nausea, hot flashes, and respiratory issues. Report any concerning or severe side effects immediately. Management strategies may be available. Prior to treatment, disclose any history of vaginal bleeding, ovarian cysts, or uterine tumors. Complete disclosure of all medications is crucial, as interactions could impact efficacy. Inform your doctor if you are pregnant or breastfeeding.

Primary Ingredients of Bravelle 75I.U Injection

No text provided. Please provide the text you would like me to rephrase.

Uses of Bravelle 75I.U Injection

Inability to conceive in women

Major Benefits of Bravelle 75I.U Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Bravelle 75I.U Injection:

  • Abdominal pain
  • Headache
  • Bloating
  • Pelvic pain
  • Abdominal cramp
  • Nausea
  • Respiratory disorder
  • Hot flushes

How to use Bravelle 75I.U Injection:

This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.

How Bravelle 75I.U Injection works:

Bravelle 75 IU Injection promotes egg maturation and release in women by increasing estrogen production. This action is particularly beneficial during assisted reproductive technology treatments, where it encourages the development of multiple follicles.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while using Bravelle 75 I.U. Injection is inadvisable.

PregnancyPregnancyUNSAFE

The administration of Bravelle 75 I.U. Injection is contraindicated in pregnancy. Pregnant individuals should consult their physician, as research in both animal and human subjects has revealed substantial adverse effects on fetal development.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on Bravelle 75I.U Injection use while breastfeeding is lacking. Seek medical advice from your physician.

DrivingDrivingSAFE

Driving ability is typically unaffected by Bravelle 75 I.U. Injection.

KidneyKidneyCONSULT YOUR DOCTOR

Data regarding Bravelle 75 I.U. Injection use in individuals with renal impairment is scarce. Seek medical advice from your physician.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding Bravelle 75I.U Injection use in individuals with hepatic impairment. Physician consultation is advised.

What if you forget to take Bravelle 75I.U Injection :

Omit a dose of Bravelle 75I.U Injection? Seek your physician's advice.

Facts to Know About Bravelle 75I.U Injection

LabelValue
Chemical Category Endocrine Signals
Developing Habits No.
Treatment Category Obstetrics and Gynecology
Actions Reproductive hormones

FAQs on Bravelle 75I.U Injection

Administered subcutaneously by a healthcare professional only, the dosage and treatment length are determined by your ovarian response and require ongoing medical supervision.
Don't miss a dose of Bravelle 75 IU Injection if possible. If you do miss a dose, contact your doctor immediately.
Headache and abdominal pain are the most frequent side effects. Other common side effects include hot flashes, nausea, vomiting, diarrhea, rashes, and breast tenderness. Consult your doctor if any side effects are bothersome. This medication may also increase the risk of ovarian hyperstimulation syndrome (OHSS) and multiple pregnancy.
Bravelle 75 IU Injection, containing Urofollitropin (a follicle-stimulating hormone or FSH), treats infertility in women whose ovaries don't produce enough eggs, including those with polycystic ovary disease (PCOD). It's also used in assisted reproductive technologies (ART) like in-vitro fertilization (IVF).
Bravelle 75I.U Injection
1,239
MRP 1,435
13% off